Sensex
82,380.69 profit arw 594.95 (0.73%)
Nifty
25,239.10 profit arw 169.90 (0.68%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 08-Sep-2025
Hot Pursuit
08-Sep-2025     09:19

Dr Reddy's Labs UK facility flagged with 7 USFDA observations

According to a regulatory filing, the inspection was conducted from 1 September to 5 September 2025. On conclusion, the USFDA issued a Form-483 with seven observations.

Hyderabad-based Dr. Reddy's Laboratories is a global pharmaceutical company. It offers a portfolio of products and services, including APIs, generics, branded generics, biosimilars, and OTC.

The company's consolidated net profit rose 1.8% to Rs 1,418.10 crore on an 11.4% increase in revenue from operations to Rs 8,545.20 crore in Q1 FY26 over Q1 FY25.

Shares of Dr Reddys Laboratories shed 0.04% to Rs 1,268 on the BSE.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

82,380.69 594.95 (0.73%)

Nifty

25,239.10 169.90 (0.68%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

26,438.52 -8.05(-0.03%)